共 229 条
[1]
Bunn F(2014)Comorbidity and dementia: a scoping review of the literature BMC Med 12 192-604
[2]
Burn AM(2018)Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications Nat Rev Endocrinol. 14 591-1236
[3]
Goodman C(2018)Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis J Alzheimers Dis 65 1225-73
[4]
Rait G(2020)Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer’s disease, and the role APOE carrier status Alzheimers Dement. 16 1663-921
[5]
Norton S(2012)Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control study J Am Geriatr Soc 60 916-181
[6]
Robinson L(2014)Vitamin B12 status in metformin treated patients: systematic review PLoS One 9 e100379-109
[7]
Biessels GJ(2018)Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums Nat Rev Neurol 14 168-572
[8]
Despa F(2020)Safety, efficacy, and feasibility of Intranasal Insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: A Randomized Clinical Trial JAMA Neurol. 77 1099-507
[9]
Campbell JM(2014)Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial Lancet Diabetes Endocrinol 2 562-1885
[10]
Stephenson MD(2019)Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study Eur J Endocrinol 181 499-2498